Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.

Neofytos, Dionysios;Chatzis, Olga;Nasioudis, Dimitrios;Boely Janke, Elsa;Swiss Transplant Cohort Study;et.al.
(2018) Transplant Infectious Disease (Print) — Vol. 20, n° 4, p. e12898 [1-11] (2018)

Files

No attached file found for this publication.

Details

Authors
  • Neofytos, Dionysiosorcid-logo
    Author
  • Chatzis, OlgaUCLouvain
    Author
  • Nasioudis, Dimitrios
    Author
  • Boely Janke, Elsa
    Author
  • Swiss Transplant Cohort Study
    Collaborator
Show more
Abstract
(en) BACKGROUND: There is lack of recent multicenter epidemiological data on invasive aspergillosis (IA) among solid organ transplant recipient (SOTr) in the mold-acting antifungal era. We describe the epidemiology and outcomes of IA in a contemporary cohort of SOTr using the Swiss Transplant Cohort Study. METHODS: All consecutive SOTr with proven or probable IA between 01.05.2008 and 31.12.2014 were included. A case-control study to identify IA predictors was performed: 1-case was matched with 3-controls based on SOT type, transplant center, and time post-SOT. RESULTS: Among 2868 SOTr, 70 (2.4%) patients were diagnosed with proven (N: 30/70, 42.9%) or probable (N: 40/70, 57.1%) IA. The incidence of IA was 8.3%, 7.1%, 2.6%, 1.3%, and 1.2% in lung, heart, combined, kidney, and liver transplant recipients, respectively, Galactomannan immunoassay was positive in 1/3 of patients tested. Only 33/63 (52.4%) of patients presented with typical pulmonary radiographic findings. Predictors of IA included: renal insufficiency, re-operation, and bacterial and viral infections. 12-week mortality was higher in liver (85.7%, 6/7) compared to other (15.9%, 10/63; P < .001) SOTr. CONCLUSIONS: Invasive aspergillosis remains a rare complication post-SOT, with atypical radiographic presentations and low positivity rates of biomarkers posing significant diagnostic challenges. Although overall mortality has decreased in SOTr, it remains high in liver SOTr.
Affiliations

Citations

Neofytos, D., Chatzis, O., Nasioudis, D., Boely Janke, E., Doco Lecompte, T., Garzoni, C., Berger, C., Cussini, A., Boggian, K., Khanna, N., Manuel, O., Mueller, N. J., & van Delden, C. (2018). Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study. Transplant Infectious Disease (Print), 20(4), e12898 [1-11]. https://doi.org/10.1111/tid.12898 (Original work published 2018)